-
1
-
2
Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability
Published 2025-02-01Subjects: Get full text
Article -
3
Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report
Published 2025-03-01Subjects: “…Tyrosine kinase inhibitors (TKI)…”
Get full text
Article -
4
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
Published 2025-03-01Subjects: “…Tyrosine kinase inhibitor (TKI)…”
Get full text
Article